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Abstract The cyclic AMP receptor protein activates transcrip-
tion in Escherichia coli, only when complexed with cyclic AMP.
The cyclic AMP receptor protein-cyclic AMP complex formed
at low concentrations of cyclic AMP has a different conforma-
tion from either cyclic AMP receptor protein alone or its
complex with cyclic AMP formed at high cyclic AMP
concentrations. Various biophysical data suggest that the latter
complex resembles free cyclic AMP receptor protein. We have
examined the conformational and biological properties of cyclic
AMP receptor protein as a function of cyclic AMP concentra-
tions, using the gal operon of E. coli. A biphasic behavior is
observed. It is shown that only the complex formed at lower
concentrations of cyclic AMP is the transcriptionally active
form. This difference between the complexes at different levels of
cyclic AMP arises from a decreased ability of the cyclic AMP
receptor protein-cyclic AMP complex at high cyclic AMP
concentrations to bind to DNA at specific sites.
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1. Introduction
The cyclic AMP (cAMP) receptor protein (CRP) plays a
key role in the regulation of expression of many genes [1^3]
in bacteria. CRP is a homodimer of two 209 residue subunits
[3]. Activation or repression of transcription by CRP requires
that it binds cAMP and undergoes an allosteric conforma-
tional change which is essential for its binding to DNA at
speci¢c sites [4^7]. However, cAMP binds to each CRP mono-
mer at two di¡erent sites with di¡erent a⁄nities [8]. Higher
a⁄nity sites where the nucleotide binds in the anti conforma-
tion are located in the N-terminal domains, whereas lower
a⁄nity binding sites (where the bound cAMP has a syn con-
formation) are located at the interface formed by the two C-
terminal domains of the CRP subunits. Therefore, it has been
suggested that CRP exists in three conformational states: free
CRP, CRP with two cAMP molecules bound to N-terminal
domains, CRP-(cAMP)2, and CRP with four cAMP mole-
cules bound to both N-terminal and C-terminal domains,
CRP-(cAMP)4. Earlier, it was proposed [7] that the three
conformational states of CRP consisted of the following spe-
cies: free CRP, CRP-(cAMP)1 and CRP-(cAMP)2, which
have been re-interpreted by Passner and Steitz [8] in the light
of the recent crystal structure data. For our purpose, it is
su⁄cient to note that the behavior of CRP at di¡erent con-
centrations of cAMP is essentially biphasic, so that two di¡er-
ent conformers exist at lower and higher concentrations of
cAMP. We shall refer to these conformers as the ‘anti com-
plex’ and the ‘syn complex’.
It is known that the level of cAMP regulates the expression
of many genes in Escherichia coli, this regulation being medi-
ated by CRP. It is, however, not yet known whether or not
both forms of cAMP-CRP complexes are competent in tran-
scription regulation. Predominantly from biophysical experi-
ments, it has been suggested that the syn complex resembles
unliganded CRP, while the conformation of the anti complex
is di¡erent [7]. This suggestion has led to the hypothesis that
perhaps the anti complex is the active form that plays a role in
regulation of transcription, while the syn complex is inactive.
We have examined the e¡ect of increasing concentrations of
cAMP on (a) the conformation of CRP, (b) regulation of
transcription in the E. coli galactose operon and (c) DNA
binding properties of CRP, to evaluate the above hypothesis.
2. Materials and methods
2.1. Materials
CRP was puri¢ed from the strain pp47 harboring plasmid pHA7
according to the method used by Ryu et al. [9] with the following
modi¢cation. A Superdex-75 column (Pharmacia) was used in the
¢nal step, instead of the mono-S column. The protein obtained was
at least 98% pure, as judged by Coomassie blue staining following
SDS-PAGE. RNA polymerase and nucleotide triphosphates (Pharma-
cia), cAMP and 5,5P-dithiobis(2-nitrobenzoic acid) (DTNB) (Sigma)
and [32P-K]UTP (BRIT, India) were purchased from the indicated
sources. Concentrations were determined spectrophotometrically, us-
ing O= 14 650 M31 cm31 at 258 nm for cAMP [10] and 20 400 M31
cm31 at 278 nm for CRP [11].
2.2. Chymotrypsin digestion
Proteolysis of CRP was carried out in 40 mM Tris-HCl (pH 8.0)
with 0.1 M KCl, 0.1 mM DTT, 10 mM MgCl2, 0.2 mM EDTA by
incubating CRP (8.5 Wg) with chymotrypsin (0.4 Wg) at 28‡C for
20 min at various cAMP concentrations. Digested products were
run on a 13.5% SDS-PAGE followed by Coomassie blue staining
and then analyzed by densitometric scanning with a GS-700 densi-
tometer (Bio-Rad).
2.3. Determination of the accessibility of SH groups
The accessibility of cysteine residues in CRP at di¡erent cAMP
concentrations was determined by treating 900 Wl protein solution
(in 100 mM K-phosphate bu¡er, pH 8.0) with 100 Wl DTNB, at
room temperature (25‡C). Final concentrations of protein and
DTNB were 1 WM and 30 WM, respectively. The number of free
cysteine residues was determined from the changes in absorbance at
412 nm as 2-nitro-5-thiobenzoate (TNB) molecules released in the
reaction, using O of TNB = 13 600 M31 cm31 at 412 nm [12].
2.4. Intersubunit crosslinking of Cys-178 residues by DTNB
10 WM CRP was treated with 100 WM DTNB for 20 min at 22‡C, to
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e¡ect S-S crosslinking between the Cys-178 residues of the two sub-
units. The mixture was then run on a 13.5% SDS-PAGE to separate
the crosslinked species from the uncrosslinked one.
2.5. In vitro transcription
Reactions were performed in a 20 Wl volume, in transcription bu¡er
(40 mM Tris-Cl, pH 8.0, 0.1 M K-glutamate, 1 mM DTT, 20 mM
MgCl2), using 2 nM of a 346 bp DNA fragment (EcoRI-BamHI frag-
ment of pSA 509 [13]) containing gal promoters as template and
100 nM CRP, cAMP (0^400 WM) and 50 nM RNA polymerase. Ex-
periments were done in two ways. In the ¢rst procedure, 100 nM CRP
and a speci¢c amount of cAMP were incubated on ice for 5 min to
form the cAMP-CRP complex and then added to the reaction mix-
ture. In the second method, cAMP was added to the reaction mixture
containing 100 nM CRP and the rest of the components. After in-
cubation at 37‡C for 20 min, transcription was initiated by the addi-
tion of the nucleotide mix (0.1 mM each of ATP, GTP, CTP;
0.01 mM UTP, 5 WCi [32P]UTP at 3000 Ci/mmol and 1 Wg heparin)
and terminated after 20 min by adding 10 Wl of formamide loading
bu¡er (90% formamide, 20 mM EDTA, 0.05% bromophenol blue,
0.05% xylene cyanol). Transcribed RNA was resolved by electropho-
resis on a 10% polyacrylamide-7 M urea gel. The amounts of tran-
scripts were quantitated with a Bio-Rad Phosphorimager.
2.6. DNA binding studies
DNA fragments containing gal promoters as well as the CRP bind-
ing site were ampli¢ed by PCR from the plasmid pSA509 [13], obtain-
ing 298 bp double-stranded linear DNA. 1.0 WM CRP (in 40 mM
Tris-Cl (pH 8.0) with 0.2 M KCl, 0.1 mM DTT, 20 mM MgCl2)
was titrated with the above DNA in the presence of cAMP at di¡erent
concentrations. The DNA binding of CRP was monitored by the
change in the £uorescence intensity at 345 nm, measured in a Hitachi
F-3000 spectro£uorometer. Excitation was at 295 nm. Bandwidths of
5 nm were used on both sides.
3. Results
3.1. Proteolysis by chymotrypsin
It has been shown that digestion by various proteases in-
cluding chymotrypsin is an indicator of the conformational
state of CRP [6,7]. Free CRP is resistant to proteolysis and
is digested only in the presence of cAMP, producing a 13 kDa
fragment in SDS-PAGE (indicating that the cleavage occurs
at F136). We studied the e¡ect of increasing amounts of
cAMP on the cleavage of CRP. Our results (Fig. 1) show
that the sensitivity to chymotrypsin exhibits a biphasic behav-
ior, with the maximum sensitivity (V80%) occurring near
200 WM cAMP (lane d). A further increase in the concentra-
tion of the ligand reduces this sensitivity and at 10 mM
cAMP, this becomes 38% (lane h). Thus, the conformational
change induced by the binding of cAMP is reversed at higher
levels of the ligand.
3.2. Accessibility of C-178 residues
CRP has three Cys residues per monomer, of which only C-
178, located near the DNA binding region of the protein, is
accessible to modi¢cation by DTNB [12]. Thus, two Cys res-
idues are accessible to react with DTNB, per dimer of CRP.
When the number of accessible Cys residues was estimated as
a function of cAMP concentrations, this number also showed
a biphasic dependence on cAMP, decreasing to a minimum
value of 1.5 at 0.1 mM cAMP and increasing again when the
cAMP concentration was increased (Fig. 2). It has been re-
ported that DTNB induces disul¢de bond formation between
the C-178 residues of the two subunits of CRP [12]. Thus, the
observed decrease in the sensitivity of Cys -SH groups at
intermediate levels of cAMP may result from the crosslinking
of the -SH groups. Such a crosslinking may not be possible
for the syn complex, which has an altered conformation. We
veri¢ed this possibility in the intersubunit crosslinking experi-
ment carried out at di¡erent cAMP concentrations described
below.
Crosslinking between the -SH groups of C-178 residues in
CRP subunits by DTNB results in a 45 kDa band in SDS-
PAGE, as shown in Fig. 3 (lanes a^e). CRP was subjected to
crosslinking by DTNB at cAMP concentrations ranging from
0 to 10 mM. It is observed that crosslinking occurs at low
cAMP concentrations but the extent of crosslinking goes
down at high cAMP concentrations. The di¡erential behavior
of the C-178 groups at low and high cAMP suggests that the
conformations of the two cAMP-CRP complexes are di¡er-
ent. It was further examined whether the crosslinked protein
(as in lane c) is sensitive to chymotrypsin cleavage, after re-
moval of cAMP (Fig. 3, lane g). As a control, a CRP-cAMP
complex was formed at 1 mM cAMP and was also subjected
to a similar treatment by chymotrypsin before (lane f) and
after (lane h) removing cAMP. Indeed, cAMP could be re-
moved from these complexes, as judged from the absence of
Fig. 1. Proteolysis of CRP by chymotrypsin, in the presence of
varying concentrations of cAMP. Lane a, molecular weight marker.
Lanes b^h contained cAMP as shown (¢gures in brackets represent
the percentage of CRP digested, as measured by densitometry):
(b) 0 (5%), (c) 20 WM (41%), (d) 200 WM (79%), (e) 1 mM (84%),
(f) 2 mM (67%), (g) 5 mM (44%) and (h) 10 mM (38%).
Fig. 2. The number of accessible cysteine residues per CRP dimer,
at various cAMP concentrations. S.D.s are indicated.
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digested product in lane h. The crosslinked protein shows
sensitivity to chymotrypsin (as evidenced by the 13 kDa
band) even in the absence of cAMP (lane g). Thus, the cross-
linking of the subunits probably ¢xes the conformation of the
protein in the form that is similar to the anti complex.
3.3. In vitro transcription of gal promoters
All the results described above clearly point to di¡erent
conformations of the cAMP-CRP complexes at low and
high cAMP. Are these conformations involved in the regula-
tion of transcription? A 346 bp linear DNA containing pro-
moter region of the galactose operon of E. coli was used as a
template to carry out in vitro transcription experiments at
various cAMP concentrations, to answer the above question.
This operon has two overlapping promoters, P1 and P2, sep-
arated by 5 bp, which are di¡erentially regulated by cAMP-
CRP. In the absence of cAMP, transcripts are produced both
from P1 and P2 while in its presence, P1 is activated and P2 is
repressed [14,15]. Thus, the galactose operon is a suitable
system to test the e¡ects of the two types of cAMP-CRP
complexes described above. Run-o¡ transcripts of 149 and
154 bp lengths are expected to be produced from P1 and
P2, respectively, from the template used. CRP was pre-incu-
bated with increasing concentrations of cAMP, before addi-
tion of the other components and initiating transcription. As
seen from Fig. 4A, P1 is activated and P2 repressed, up to
[cAMP] = 100 WM (lane e). Further addition of cAMP tends
to reverse this e¡ect and at 400 WM cAMP (lane g), about
30% of the transcripts are from P2. This biphasic nature of
the activation/repression by CRP as a function of cAMP con-
centrations correlates with a similar biphasic change in the
conformations of the complexes. The same experiment was
also performed by changing the order of addition. CRP was
¢rst incubated with DNA and RNA polymerase, followed by
the addition of cAMP and NTP mix to initiate transcription
(Fig. 4B). In this case, there is a monotonic increase in the
activation of P1 coupled with a repression of P2, all the way
up to 400 WM cAMP. A result similar to that shown in Fig.
4B was also reported by Choy and Adhya [13], for cAMP up
to 200 WM. The di¡erence between the results of Fig. 4A and
B is probably due to the fact that when anti complex is bound
to DNA at speci¢c sites, further binding of cAMP is pre-
cluded.
Fig. 3. Intersubunit crosslinking of CRP monomers by DTNB, at
various cAMP concentrations. Lane a: no cAMP, no DTNB; lanes
b^e: treated with DTNB, at [cAMP] = 0, 1, 5 and 10 mM. Sensitiv-
ity to proteolysis by chymotrypsin was also checked for the cross-
linked protein, after removal of cAMP (lane g, which is similar to
CRP as in lane c, having 1 mM cAMP). For comparison, proteoly-
sis of CRP at 1 mM cAMP before (lane f) and after (lane h) re-
moval of cAMP by passing through a Sephadex G-25 spun column
is also shown.
Fig. 4. The e¡ect of cAMP on in vitro transcription from gal pro-
moters. Run-o¡ transcripts from P1 and P2 promoters are indi-
cated. cAMP concentrations used were 0, 0.2, 2, 20, 100, 200 and
400 WM (lanes a^g). (A) CRP was pre-incubated with the indicated
amount of cAMP, allowing cAMP-CRP interaction to precede inter-
action with DNA. (B) CRP was added to DNA and RNA polymer-
ase, prior to addition of the speci¢ed amount of cAMP, so that
CRP-DNA interactions preceded interaction with cAMP. The radio-
active counts in each lane were not always equal. The minor tran-
scripts migrating faster than gal P1 and P2 originate from prema-
ture termination at a partial rho-independent terminator sequence
near the 5P end of the DNA template.
Fig. 5. Binding of CRP to DNA, at di¡erent cAMP conditions.
Relative quenching of the £uorescence intensity (vF/F0, where
vF = F03F, F0 and F indicate the £uorescence in the absence and
presence of DNA) is plotted as a function of the added DNA con-
centration. CRP was kept ¢xed at 1 WM. The quenching curves
arise from binding of the protein to DNA and the initial slopes in-
dicate the strength of binding. Note the increase of this slope when
cAMP is changed from 0 to 25 WM and its return to the starting
level at 2 mM cAMP.
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3.4. Interaction of the di¡erent cAMP-CRP conformers with
DNA
In the light of the recent three dimensional structure of the
cAMP-CRP complex [8], it is known that at high cAMP con-
centrations, the lower a⁄nity (syn) cAMP binding sites are
likely to be occupied, which might interfere with DNA bind-
ing at speci¢c sites. This loss of DNA binding may account
for the reversal of activation of P1 (and repression of P2) at
high cAMP, as in Fig. 4A. We tested this possibility by meas-
uring the DNA binding capability of the two CRP complexes
(formed at low and high cAMP) described below.
When DNA is added to CRP, the tryptophan £uorescence
of the protein is quenched. In a control experiment, we
checked that when DNA was added to bovine serum albumin,
which does not bind to DNA, no quenching occurred (data
not shown). This quenching was therefore used to assess the
DNA binding ability of CRP. The tryptophan £uorescence
emission was measured at DNA concentrations ranging
from 0 to 120 nM, for each of the following three cases,
viz. (i) CRP alone, (ii) low (25 WM) cAMP, and (iii) high (2
mM) cAMP (see Fig. 5). The quenching curves (i) and (iii)
almost coincide, whereas that for the low cAMP conformer
(ii) is distinct, with an enhanced quenching e¡ect. Since it is
known that free CRP does not exhibit strong and speci¢c
binding to DNA [16], we interpret these quenching data (at
zero and high cAMP) as an indication of non-speci¢c binding
of CRP to DNA. On the other hand, the anti complex binds
to DNA at speci¢c sites, with a strong a⁄nity. Thus, the
reduced activation of transcription by CRP at high cAMP
levels is a consequence of the inability of the complex to
bind to DNA at speci¢c sites. It may be pointed out that
Heyduk and Lee [7] also showed by gel mobility shift experi-
ments that CRP loses its capacity to bind to DNA as the
cAMP concentration is increased.
4. Discussion
The allosteric transformation of CRP from a transcription-
ally inert complex to an active one in the presence of cAMP
appears to be crucially dependent on the cAMP:CRP ratio.
While activation/repression is apparent at low cAMP concen-
trations, at high cAMP concentrations, a second inactive con-
former of cAMP-CRP is formed that is unable to speci¢cally
bind to DNA with a signi¢cant a⁄nity. Extra cAMP mole-
cules bound at the low a⁄nity sites in the C-terminal domain
of CRP would interfere with its DNA binding property. Thus,
when the syn complex formed at high concentrations of
cAMP is allowed to interact with DNA, there is little binding
(Fig. 5) and also the activation of gal P1 is reduced (Fig. 4A).
When the anti complex interacts with DNA, further cAMP
binding cannot occur and there is activation of gal P1 even at
high concentrations of cAMP (Fig. 4B). This observation has
two consequences. First, the regulation of transcription by
cAMP-CRP may have a much ¢ner control than believed so
far, a change in the level of cAMP can cause a signi¢cant
perturbation to the activation. Thus, the level of cAMP would
dictate whether or not the cAMP-CRP complex would be
involved in regulation, rather than the mere presence or ab-
sence of the ligand. Moreover, the order of cAMP binding,
i.e. whether cAMP binds to free CRP or to DNA-bound
CRP, should also dictate the regulatory events. Secondly,
the reported crystal structure of the ternary cAMP-CRP-
DNA complex [8] contains high cAMP concentrations in
which the syn complex (i.e. the complex that does not inacti-
vate) predominates. It is thus possible that the interactions
between the ligand, the protein and DNA, as predicted from
the crystal structure data, only indicate certain possible inter-
actions and do not represent the interactions occurring in the
activation complex.
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